BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26747736)

  • 1. Analysis of circulating CD14+/CD16+ monocyte-derived macrophages (MDMs) in the peripheral blood of patients with oral squamous cell carcinoma.
    Grimm M; Feyen O; Coy JF; Hofmann H; Teriete P; Reinert S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):301-6. PubMed ID: 26747736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a biomarker based blood test for monitoring surgical resection of oral squamous cell carcinomas.
    Grimm M; Kraut W; Hoefert S; Krimmel M; Biegner T; Teriete P; Cetindis M; Polligkeit J; Kluba S; Munz A; Reinert S
    Clin Oral Investig; 2016 Mar; 20(2):329-38. PubMed ID: 26153867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of circulating CD14
    Song Y; Zhou Q; Zhu H; Jing Y; Zhang X; Yang Y; Hu Q; Huang X; Ni Y
    J Oral Pathol Med; 2018 Nov; 47(10):923-929. PubMed ID: 29961993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
    Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
    Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells.
    Grimm M; Schmitt S; Teriete P; Biegner T; Stenzl A; Hennenlotter J; Muhs HJ; Munz A; Nadtotschi T; König K; Sänger J; Feyen O; Hofmann H; Reinert S; Coy JF
    BMC Cancer; 2013 Dec; 13():569. PubMed ID: 24304513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the proportion of non-classic (CD14+CD16+) monocytes/macrophages in peripheral blood and gingiva of healthy individuals and patients with chronic periodontitis.
    Jagannathan R; Lavu V; Rao SR
    J Periodontol; 2014 Jun; 85(6):852-8. PubMed ID: 24001047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers Apo10 and TKTL1: Epitope-detection in monocytes (EDIM) as a new diagnostic approach for cholangiocellular, pancreatic and colorectal carcinoma.
    Saman S; Stagno MJ; Warmann SW; Malek NP; Plentz RR; Schmid E
    Cancer Biomark; 2020; 27(1):129-137. PubMed ID: 31771043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
    Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
    Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus.
    Burbano C; Vasquez G; Rojas M
    Arthritis Rheumatol; 2014 Dec; 66(12):3371-81. PubMed ID: 25168844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings.
    Arslan U; Kocaoğlu I; Balci MM; Gülkan B; Falay MY; Temizhan A
    Coron Artery Dis; 2013 Aug; 24(5):404-11. PubMed ID: 23612365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
    Czepluch FS; Kuschicke H; Dellas C; Riggert J; Hasenfuss G; Schäfer K
    J Intern Med; 2014 Feb; 275(2):144-54. PubMed ID: 24118494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction.
    Tsujioka H; Imanishi T; Ikejima H; Kuroi A; Takarada S; Tanimoto T; Kitabata H; Okochi K; Arita Y; Ishibashi K; Komukai K; Kataiwa H; Nakamura N; Hirata K; Tanaka A; Akasaka T
    J Am Coll Cardiol; 2009 Jul; 54(2):130-8. PubMed ID: 19573729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of Toll-like receptor 4 and human monocyte subsets in acute myocardial infarction.
    Kashiwagi M; Imanishi T; Ozaki Y; Satogami K; Masuno T; Wada T; Nakatani Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Akasaka T
    Atherosclerosis; 2012 Mar; 221(1):249-53. PubMed ID: 22244044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between different monocyte subsets and coronary collateral development.
    Arslan U; Kocaoğlu İ; Falay MY; Balcı M; Duyuler S; Korkmaz A
    Coron Artery Dis; 2012 Jan; 23(1):16-21. PubMed ID: 22045058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of radical prostatectomy on levels of cancer related epitopes in circulating macrophages of patients with clinically localized prostate cancer.
    Todenhöfer T; Hennenlotter J; Keller G; Neumann T; Stenzl A; Bedke J
    Prostate; 2017 Sep; 77(12):1251-1258. PubMed ID: 28726251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium.
    Suzuki A; Fukuzawa K; Yamashita T; Yoshida A; Sasaki N; Emoto T; Takei A; Fujiwara R; Nakanishi T; Yamashita S; Matsumoto A; Konishi H; Ichibori H; Hirata KI
    Europace; 2017 Jan; 19(1):40-47. PubMed ID: 26826137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcript profiling of CD16-positive monocytes reveals a unique molecular fingerprint.
    Frankenberger M; Hofer TP; Marei A; Dayyani F; Schewe S; Strasser C; Aldraihim A; Stanzel F; Lang R; Hoffmann R; Prazeres da Costa O; Buch T; Ziegler-Heitbrock L
    Eur J Immunol; 2012 Apr; 42(4):957-74. PubMed ID: 22531920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study.
    Amoruso A; Sola D; Rossi L; Obeng JA; Fresu LG; Sainaghi PP; Pirisi M; Brunelleschi S
    Pharmacol Res; 2016 May; 107():308-314. PubMed ID: 27045818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
    Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective expansion of the CD14(+)/CD16(bright) subpopulation of circulating monocytes in patients with hemophagocytic syndrome.
    Takeyama N; Yabuki T; Kumagai T; Takagi S; Takamoto S; Noguchi H
    Ann Hematol; 2007 Nov; 86(11):787-92. PubMed ID: 17619880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.